GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Addex Therapeutics ADXN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

0.02

-2.88%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Addex Therapeutics — daily SIX:ADXN End of day
Market value
CHF 2.0m
Last close × shares
Volume
448k
Shares, 9 Nov 2026

About Addex Therapeutics

Its shares trade on SIX under the ticker ADXN.SW. It has been listed since 22 May 2007. In the fiscal year to 31 December 2025, it reported revenue of CHF 173,000 and a net loss of CHF 6.7m. At that date it held total assets of CHF 6.4m and shareholders' equity of CHF 4.8m.

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. The company is headquartered in Plan-Les-Ouates, Geneve. The company went IPO on 2007-05-22. The firm focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. The company also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.

Figures and description from our data supplier, not checked against the company's own report.

More about Addex Therapeutics →

Latest on Addex Therapeutics

Our reporting

We have not reported on Addex Therapeutics yet.

Next results

9 Nov 2026

Due on 9 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Addex Therapeutics's ticker?

Addex Therapeutics trades as ADXN.SW on SIX, under ISIN CH0029850754.

What was Addex Therapeutics's last closing price?

0.02 on 9 Nov 2026. The figure is in CHF and is never converted.

When does Addex Therapeutics next report results?

Results are expected on 9 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.